This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Shahadat Ahmed, PhD
Head Integrated Drug Discovery at Aurigene Pharmaceutical Services
Speaker

Profile

Shahadat Ahmed is the Head of Integrated Drug Discovery at Aurigene Pharmaceutical Services Limited. He is a highly accomplished medicinal chemist with extensive experience in oncology and drug discovery. Shahadat has played a key role in leading discovery chemistry efforts, including peptide and oligonucleotide therapeutics. He holds a senior leadership position and has immensely contributed to Aurigene’s integrated drug discovery platform, focusing on innovative solutions in medicinal chemistry. He is also a co-inventor of several compounds active in preclinical and clinical phases.

Agenda Sessions

  • Attaching Novel Albumin Binders to Modulate Peptides Stability and Pharmacokinetics

    12:50